BlueRock Therapeutics

BlueRock Therapeutics is a biotechnology company planning to develop induced pluripotent stem cell (iPSC) therapies and utilize industry-leading platforms to treat a range of diseases. Heart attacks (myocardial infarction) or chronic heart failure are leading causes of morbidity and mortality worldwide, and one of BlueRock Therapeutics' initial programs aims to regenerate cardiac muscle for affected patients.